Home » Topics » Regulatory

Regulatory
RSS

New use reported for a known veterinary anticoccidial agent

Jan. 31, 1997

Doxil superior to other treatments for first-line treatment of Kaposi's sarcoma

Jan. 29, 1997

New ropinirole formulation described by SKB

Jan. 29, 1997

Lilly claims new indications for olanzapine

Jan. 29, 1997

New use claimed for maprotiline

Jan. 29, 1997

New use for established antianginal agent

Jan. 29, 1997

Clinical data on AccuSite published in peer-reviewed journals

Jan. 28, 1997

Hypocholesterolemic activity of raloxifene established in rats

Jan. 28, 1997

Abbott seeks expanded labeling for Norvir

Jan. 24, 1997

Clinical results of gabapentin in ALS reported

Jan. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.